These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34819070)

  • 21. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.
    Duncan E; Shufelt S; Barranco M; Udo T
    Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
    Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
    Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV Risk Among Urban and Suburban People Who Inject Drugs: Elevated Risk Among Fentanyl and Cocaine Injectors in Maryland.
    Park JN; Owczarzak J; Urquhart G; Morris M; Weicker NP; Rouhani S; Sherman SG
    AIDS Behav; 2022 Jan; 26(1):277-283. PubMed ID: 34287755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City.
    Kapadia SN; Aponte-Melendez Y; Rodriguez A; Pai M; Eckhardt BJ; Marks KM; Fong C; Mateu-Gelabert P
    Harm Reduct J; 2023 Jul; 20(1):95. PubMed ID: 37501180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between neighborhood socioeconomic disadvantage and high-risk injection behavior among people who inject drugs.
    DeCuir J; Lovasi GS; El-Sayed A; Lewis CF
    Drug Alcohol Depend; 2018 Feb; 183():184-191. PubMed ID: 29288913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs.
    Williams LD; Lee E; Latkin C; Mackesy-Amiti ME; Kaufmann M; Copulsky E; Kaplan C; Boodram B
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study.
    Suarez E; Bartholomew TS; Plesons M; Ciraldo K; Ostrer L; Serota DP; Chueng TA; Frederick M; Onugha J; Tookes HE
    Ann Med; 2023 Dec; 55(1):733-743. PubMed ID: 36856571
    [No Abstract]   [Full Text] [Related]  

  • 28. An application of agent-based modeling to explore the impact of decreasing incarceration rates and increasing drug treatment access on sero-discordant partnerships among people who inject drugs.
    Linton SL; Jarlais DCD; Ornstein JT; Kasman M; Hammond R; Kianian B; Smith JC; Wolfe ME; Ross Z; German D; Flynn C; Raymond HF; Klevens RM; Spencer E; Schacht JM; Finlayson T; Paz-Bailey G; Wejnert C; Cooper HLF
    Int J Drug Policy; 2021 Aug; 94():103194. PubMed ID: 33812133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
    Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
    Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
    May T; Dawes J; Fancourt D; Burton A
    Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of COVID-19 vaccination among people who inject drugs.
    Iversen J; Wand H; Kemp R; Bevan J; Briggs M; Patten K; Heard S; Maher L
    Harm Reduct J; 2022 Jun; 19(1):59. PubMed ID: 35655217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
    Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
    BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial.
    El-Bassel N; McCrimmon T; Wu E; Chang M; Terlikbayeva A; Hunt T; Darisheva M; Primbetova S; Davis A; Metsch LR; Feaster DJ; Baiserkin B; Abishev A; Denebayeva A; Sagimbayev B; Kurmetova K; Mashirov K; Gilbert L
    JAMA Netw Open; 2022 Dec; 5(12):e2244734. PubMed ID: 36454567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.
    Des Jarlais DC; Arasteh K; McKnight C; Feelemyer J; Perlman DC; Tross S
    Drug Alcohol Depend; 2019 Nov; 204():107459. PubMed ID: 31521951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing and Testing the
    Calvo F; Carbonell X; Mundet C
    Front Public Health; 2020; 8():493321. PubMed ID: 33330297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia.
    Carroll JJ; Rossi SL; Vetrova MV; Blokhina E; Sereda Y; Lioznov D; Luoma J; Kiriazova T; Lunze K
    Int J Drug Policy; 2023 Jul; 117():104060. PubMed ID: 37210965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic.
    Bradley H; Austin C; Allen ST; Asher A; Bartholomew TS; Board A; Borquez A; Buchacz K; Carter A; Cooper HLF; Feinberg J; Furukawa N; Genberg B; Gorbach PM; Hagan H; Huriaux E; Hurley H; Luisi N; Martin NK; Rosenberg ES; Strathdee SA; Jarlais DCD
    Int J Drug Policy; 2022 Dec; 110():103889. PubMed ID: 36343431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants.
    Folch C; Saludes V; Reyes-Ureña J; Antuori A; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2021 Apr; 90():103057. PubMed ID: 33310634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.